Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study

BACKGROUND: Direct oral anticoagulants (DOACs) have comparable efficacy with low-molecular-weight heparin (LMWH) for the treatment of cancer-associated venous thromboembolism (VTE). Whether there is a mortality benefit of DOACs compared with warfarin in the management of VTE in cancer is not establi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Adeel M., Chiasakul, Thita, Redd, Robert, Patell, Rushad, McCarthy, Ellen P., Neuberg, Donna, Zwicker, Jeffrey I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182592/
https://www.ncbi.nlm.nih.gov/pubmed/35613184
http://dx.doi.org/10.1371/journal.pmed.1004012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182592/
https://www.ncbi.nlm.nih.gov/pubmed/35613184
http://dx.doi.org/10.1371/journal.pmed.1004012

Ejemplares similares